NO904535D0 - Fremgangsmaate for fremstilling av fenoxy-heterocykliske forbindelser. - Google Patents

Fremgangsmaate for fremstilling av fenoxy-heterocykliske forbindelser.

Info

Publication number
NO904535D0
NO904535D0 NO904535A NO904535A NO904535D0 NO 904535 D0 NO904535 D0 NO 904535D0 NO 904535 A NO904535 A NO 904535A NO 904535 A NO904535 A NO 904535A NO 904535 D0 NO904535 D0 NO 904535D0
Authority
NO
Norway
Prior art keywords
phenoxy
procedure
preparation
heterocyclic compounds
heterocyclic
Prior art date
Application number
NO904535A
Other languages
English (en)
Other versions
NO179367C (no
NO904535L (no
NO179367B (no
Inventor
Jules Freedman
Mark William Dudley
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO904535D0 publication Critical patent/NO904535D0/no
Publication of NO904535L publication Critical patent/NO904535L/no
Publication of NO179367B publication Critical patent/NO179367B/no
Publication of NO179367C publication Critical patent/NO179367C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
NO904535A 1989-10-20 1990-10-19 Analogifremgangsmåte for fremstilling av terapeutisk aktive fenoksy-heterocykliske forbindelser NO179367C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42442989A 1989-10-20 1989-10-20

Publications (4)

Publication Number Publication Date
NO904535D0 true NO904535D0 (no) 1990-10-19
NO904535L NO904535L (no) 1991-04-22
NO179367B NO179367B (no) 1996-06-17
NO179367C NO179367C (no) 1996-09-25

Family

ID=23682608

Family Applications (1)

Application Number Title Priority Date Filing Date
NO904535A NO179367C (no) 1989-10-20 1990-10-19 Analogifremgangsmåte for fremstilling av terapeutisk aktive fenoksy-heterocykliske forbindelser

Country Status (21)

Country Link
EP (1) EP0423802B1 (no)
JP (1) JP3097696B2 (no)
KR (1) KR0182808B1 (no)
CN (1) CN1028099C (no)
AR (1) AR248400A1 (no)
AT (1) ATE126217T1 (no)
AU (1) AU627627B2 (no)
CA (1) CA2027530C (no)
DE (1) DE69021490T2 (no)
DK (1) DK0423802T3 (no)
ES (1) ES2088936T3 (no)
FI (1) FI104717B (no)
GR (1) GR3017775T3 (no)
HU (1) HU207300B (no)
IE (1) IE67049B1 (no)
IL (1) IL96064A (no)
NO (1) NO179367C (no)
NZ (1) NZ235688A (no)
PH (1) PH27290A (no)
PT (1) PT95637B (no)
ZA (1) ZA908234B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT625969E (pt) * 1992-02-06 2001-08-30 Merrell Pharma Inc Compostos de arilalcoxifenoxi-imidazolina
KR100693139B1 (ko) * 2001-04-19 2007-03-13 엘지전자 주식회사 디스크 드라이브의 트레이 진동방지구조
KR100482010B1 (ko) 2002-11-05 2005-04-14 삼성전자주식회사 모니터장치
EP1958507A1 (en) 2007-02-15 2008-08-20 Syngeta Participations AG Chemical compounds
BRPI0812840A2 (pt) * 2007-07-02 2014-12-09 Hoffmann La Roche 2-imidazolinas

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE614596C (de) * 1931-07-10 1935-06-13 I G Farbenindustrie Akt Ges Verfahren zur Darstellung von ?-Glyoxalidinarylmethylolen
US2893993A (en) * 1958-06-17 1959-07-07 Searle & Co 2-aryloxyaralkyl-1, 4, 5, 6-tetrahydropyrimidines
US3897431A (en) * 1969-04-24 1975-07-29 Sterling Drug Inc 2-{8 {60 -Alkoxy-arylmethyl{9 -2-imidazolines and -1,4,5,6-tetrahydropyrimidines
DE2818367A1 (de) * 1977-04-29 1978-11-02 Ciba Geigy Ag Ektoparasitizide
DE2961710D1 (en) * 1978-10-09 1982-02-18 Ciba Geigy Ag 2-(alpha-phenoxy-alkyl)-imidazolines and their salts, their preparation and use, and agents against phytoparasitic and zooparasitic mites containing them
US4260626A (en) * 1979-03-26 1981-04-07 Richardson-Merrell Inc. Tetrahydro and imidazoline antisecretory compounds
IT1231237B (it) * 1987-09-21 1991-11-26 Angeli Inst Spa Derivati eterociclici

Also Published As

Publication number Publication date
PT95637A (pt) 1991-09-13
PT95637B (pt) 1998-04-30
AR248400A1 (es) 1995-08-18
AU6456590A (en) 1991-04-26
CN1051039A (zh) 1991-05-01
CN1028099C (zh) 1995-04-05
EP0423802A1 (en) 1991-04-24
ATE126217T1 (de) 1995-08-15
KR0182808B1 (ko) 1999-05-01
HU207300B (en) 1993-03-29
JPH03135960A (ja) 1991-06-10
CA2027530C (en) 2001-05-08
NO179367C (no) 1996-09-25
HUT55366A (en) 1991-05-28
NO904535L (no) 1991-04-22
DE69021490T2 (de) 1996-02-01
ZA908234B (en) 1991-08-28
KR910007887A (ko) 1991-05-30
FI905168A0 (fi) 1990-10-19
DE69021490D1 (de) 1995-09-14
FI104717B (fi) 2000-03-31
AU627627B2 (en) 1992-08-27
CA2027530A1 (en) 1991-04-21
IL96064A (en) 1994-11-28
EP0423802B1 (en) 1995-08-09
IE67049B1 (en) 1996-02-21
ES2088936T3 (es) 1996-10-01
NZ235688A (en) 1992-02-25
NO179367B (no) 1996-06-17
HU906514D0 (en) 1991-04-29
IE903765A1 (en) 1991-04-24
IL96064A0 (en) 1991-07-18
PH27290A (en) 1993-05-04
DK0423802T3 (da) 1995-09-18
GR3017775T3 (en) 1996-01-31
JP3097696B2 (ja) 2000-10-10

Similar Documents

Publication Publication Date Title
NO900830D0 (no) Fremgangsmaate for fremstilling av piperidinforbindelser.
NO904987L (no) Fremgangsmaate for fremstilling av indolderivater.
NO905008D0 (no) Fremgangsmaate for fremstilling av heterocykliske forbindelser.
NO902003L (no) Fremgangsmaate for fremstilling av n-heteroaryl-4-quinolinaminer.
NO901554L (no) Fremgangsmaate for fremstilling av dinatrium-cefodizim.
NO904285D0 (no) Fremgangsmaate for fremstilling av substituerte karboksytetrahydroisokinoliner.
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO892204L (no) Fremgangsmaate for fremstilling av imidazokinoxalin-forbindelser.
NO905377L (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO903043D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO913692D0 (no) Fremgangsmaate for fremstilling av karbapenemforbindelser.
NO903666D0 (no) Fremgangsmaate for fremstilling av pyrrolokinolinforbindelser.
NO901067L (no) Fremgangsmaate for fremstilling av tiofener.
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO904535L (no) Fremgangsmaate for fremstilling av fenoksy-heterocykliske forbindelser.
NO904060L (no) Fremgangsmaate for fremstilling av substituerte dibenzofuraner.
NO900969L (no) Fremgangsmaate for fremstilling av n-allymetatrifluormetylanilin.
NO905047D0 (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO904070L (no) Fremgangsmaate for fremstilling av alkanfenoner.
NO890538D0 (no) Fremgangsmaate for fremstilling av oxadiazolyl-azabicyclo-heptaner.
NO920207D0 (no) Fremgangsmaate for fremstilling av 6-methyl-oestra-4,6-diener
NO913089L (no) Fremgangsmaate for fremstilling av tetrazolforbindelser.
NO904362L (no) Fremgangsmaate for fremstilling av kromanderivater.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees